country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-145935

Copy Link Print Information

NT219

1 Cited Publications

고객리뷰

Based on 1 publication(s) in Google Scholar

NT219 is a potent and dual inhibitor of insulin receptor substrates 1/2 (IRS1/2) and STAT3. IRS1/2 and STAT3 are major signaling junctions regulated by various oncogenes. NT219 affects IRS1/2 degradation and inhibits STAT3 phosphorylation. NT219 has the potential for the research of cancer diseases.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Purity: 98.57%
CAS No.: 1198078-60-2
화학식: C₁₆H₁₄BrNO₅S
분자량:412.26

보관:

-20°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

NT219 Chemical Structure

CAS No.: 1198078-60-2

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
- Clinical Trial
Chemical Information
Publications (1)
용액&용해도
- In Vitro
순도&문서
References
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

All STAT Isoforms :

In Vitro

NT219 (5 μM, 8 or 12 days) suppresses cancer stem cell viability as monotherapy and synergizes with sotorasib to induce disintegration of established mKRAS (G12C) NSCLC spheroids^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[2]

Cell Line:

H358 (NSCLC) cells
Concentration:

5 µM
Incubation Time:

8 or 12 h
Result:

Synergized with sotorasib to suppress established spheroids.
Demonstrated a significant effect on cell viability in monotherapy treatment of established H358 (NSCLC) spheroids harboring G12C KRAS mutation.

In Vivo

NT219 (20 or 60 mg/kg, i.v., twice a week for 24 days) inhibited tumor cell growth and enhanced the anti-cancer effects of Cetuximab (HY-P9905) and Pembrolizumab (HY-P9902) in the SCC-9 cell xenograft model of recurrent and metastatic head and neck squamous cell carcinoma (NOD scid gamma mice)^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

Chemical Information

CAS No. 1198078-60-2
Appearance Solid
분자량 412.26
화학식 C₁₆H₁₄BrNO₅S
Color Yellow to brown
SMILES

OC(C=C1CNC(/C=C/C2=C(C(O)=C(C=C2)O)Br)=S)=C(C(O)=C1)O
선적

Room temperature in continental US; may vary elsewhere.
보관

-20°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Publications (1)

All

Sort by:

Journal Impact Factor

Neurotherapeutics

Reticuline modulates astrocyte and microglial responses to enhance prognosis after traumatic brain injury. [Abstract]

2025 Aug 5:e00709. PMID: 40769849

용액&용해도

In Vitro:

DMSO : ≥ 100 mg/mL (242.57 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.4257 mL

12.1283 mL

24.2565 mL

5 mM

0.4851 mL

2.4257 mL

4.8513 mL

10 mM

0.2426 mL

1.2128 mL

2.4257 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (274 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Alberto Bessudo, et al. A phase 1/2 study with open-label, dose escalation phase followed by single-arm expansion at the maximum tolerated dose to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 injection alone and in combination with cetuximab in adults with advanced solid tumors and head and neck cancer.

[2]. Reuveni H, et al. NT219, a dual inhibitor of IRS1/2 and STAT3, suppresses cancer stem cell-mediated resistance to KRASG12C and KRASG12D inhibitors in solid tumors[J]. cell, 2024, 3(2): 1.

[3]. Reuveni H, et al. NT219, a novel dual inhibitor of STAT3 and IRS1/2, demonstrates anti-tumor activity with and without cetuximab in pembrolizumab-resistant head and neck cancer PDX models[C]//Cancer Research. 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA: AMER ASSOC CANCER RESEARCH, 2020, 80(16).

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.4257 mL	12.1283 mL	24.2565 mL	60.6413 mL
	5 mM	0.4851 mL	2.4257 mL	4.8513 mL	12.1283 mL
	10 mM	0.2426 mL	1.2128 mL	2.4257 mL	6.0641 mL
	15 mM	0.1617 mL	0.8086 mL	1.6171 mL	4.0428 mL
	20 mM	0.1213 mL	0.6064 mL	1.2128 mL	3.0321 mL
	25 mM	0.0970 mL	0.4851 mL	0.9703 mL	2.4257 mL
	30 mM	0.0809 mL	0.4043 mL	0.8086 mL	2.0214 mL
	40 mM	0.0606 mL	0.3032 mL	0.6064 mL	1.5160 mL
	50 mM	0.0485 mL	0.2426 mL	0.4851 mL	1.2128 mL
	60 mM	0.0404 mL	0.2021 mL	0.4043 mL	1.0107 mL
	80 mM	0.0303 mL	0.1516 mL	0.3032 mL	0.7580 mL
	100 mM	0.0243 mL	0.1213 mL	0.2426 mL	0.6064 mL

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기

Amount: USD 0.00

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
- Clinical Trial
Chemical Information
Publications (1)
용액&용해도
- In Vitro
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

NT219

C188-9

Napabucasin

KT-333

Insulin degludec

Insulin efsitora alfa

SD-436

WB436B

KU14R

AGL-2263

Kaempferitrin

DA-JC4

Valanafusp alfa

Publications Citing Use of MedChemExpress (MCE) NT219

All STAT Isoforms

Biological Activity

Chemical Information

Publications (1)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

Bioz

NT219

C188-9

Napabucasin

KT-333

Insulin degludec

Insulin efsitora alfa

SD-436

WB436B

KU14R

AGL-2263

Kaempferitrin

DA-JC4

Valanafusp alfa

Publications Citing Use of MedChemExpress (MCE) NT219

All STAT Isoforms

Biological Activity

Chemical Information

Publications (1)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

NT219 Related Classifications

HY-145935 Related Classifications

Bioz